InjectionClinical Overview
L- Ornithine L-Aspartate Infusion 5gm per 10ml is an established pharmaceutical and nutritional agent in the Vitamins, Minerals & Nutrition category on the PMBI National Formulary. Formulated to provide micronutrient replenishment, metabolic support, or nutritional therapy according to verified pharmacopoeial standards.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Administer orally with meals or as indicated by a healthcare professional. Follow recommended daily dietary allowances.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Mild gastrointestinal fullness, nausea, harmless urine color changes. Rare: Allergic reactions.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Nutritional supplement. Do not exceed recommended daily allowance unless clinically indicated. Keep out of reach of young children.
Medical Disclaimer: Statutory Nutritional & Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice or clinical dietetic guidance. Dietary supplements, micronutrients, parenteral electrolytes, and specialized clinical nutrition should be used under the supervision of a registered medical practitioner or clinical nutritionist.
Metadoxine 500mg + Silymarin 140mg + L- Ornithin L- Aspartate 150mg Tablets
Metadoxine (500mg), Silymarin (140mg), and L-Ornithine L-Aspartate (150mg) Tablets is a hepatoprotective formulation. Silymarin (milk thistle flavonolignan) stabilizes hepatocyte plasma membranes, inhibits lipid peroxidation, and stimulates ribosomal RNA synthesis to accelerate liver regeneration. Metadoxine accelerates ethanol and acetaldehyde clearance, restoring cellular ATP and glutathione. LOLA enhances ammonia detoxification via the hepatic urea cycle. Indicated for alcoholic liver disease, non-alcoholic fatty liver disease (NAFLD/NASH), acute and chronic hepatitis, and early liver cirrhosis.
L-Ornithine L-Aspartate 150mg + Pancreatin 100mg Tablets
L-Ornithine L-Aspartate (150mg) and Pancreatin (100mg) Tablets combines an ammonia-detoxifying metabolic amino acid with digestive pancreatic enzymes. LOLA stimulates urea cycle carbamoyl phosphate synthetase in hepatocytes and glutamine synthesis in skeletal muscle, clearing neurotoxic ammonia. Pancreatin supplies amylase, lipase, and protease to assist nutrient breakdown in patients with compromised digestion. Indicated for hepatic dysfunction, fatty liver, subclinical hepatic encephalopathy, and digestive insufficiency associated with liver cirrhosis.
L-Ornithine L-Aspartate 150mg + Pancreatin 100mg Tablets
L-Ornithine L-Aspartate (150mg) and Pancreatin (100mg) Tablets combines an ammonia-detoxifying metabolic amino acid with digestive pancreatic enzymes. LOLA stimulates urea cycle carbamoyl phosphate synthetase in hepatocytes and glutamine synthesis in skeletal muscle, clearing neurotoxic ammonia. Pancreatin supplies amylase, lipase, and protease to assist nutrient breakdown in patients with compromised digestion. Indicated for hepatic dysfunction, fatty liver, subclinical hepatic encephalopathy, and digestive insufficiency associated with liver cirrhosis.